pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

HHS reverses stance on disability lawsuit amid reports of falling overdose deaths and AI device access

Sep 3, 2026·read at STAT ↗RegulatoryNeutral

The Department of Health and Human Services has changed its position on a pending disability lawsuit, signaling a shift in its legal strategy.

Data released this year show a sharp decline in U.S. drug overdose deaths, with a 27% drop reported for 2024 and early figures suggesting a continued decrease in 2025.

Epidemiologists note the trend is unprecedented but caution that the drivers of the decline remain unclear.

A separate report highlights new pathways for patients to obtain artificial intelligence–based medical devices, adding another dimension to ongoing health policy discussions.

The newsletter also covers additional health news, reflecting broader changes in the healthcare landscape.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “HHS flip-flops on disability lawsuit”

read at STAT ↗
1,051 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATH3
drugs
nirmatrelvir + ritonavir
topics
Vaccine4Psychiatry & CNS2AdComCardiologyInfectious DiseaseVaccines

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 27What happened to Covid?STAT
  • 54m agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 1d agoHHS spins a tale of a would-be content creator childSTAT
  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT